Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs

Mariangela Atteno, Rosario Peluso, Luisa Costa, Stefania Padula, Salvatore Iervolino, Francesco Caso, Alessandro Sanduzzi, Ennio Lubrano, Antonio Del Puente, Raffaele Scarpa

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs'. Together they form a unique fingerprint.

Medicine & Life Sciences